Besides tumor cells, we observed that CMs from Oct4- and c-Myc-overexpressing non-tumor cells (MSCs and MLO-A5 osteocytes) also presented anti-tumor capabilities (Figure 5A-B, Figure S5). The gene discussed is MYC; the disease is neoplasm.